Work

Host Genotype-Specific Therapies Can Optimize the Inflammatory Response to Mycobacterial Infections

Year: 2012

Type: article

Source: Cell

DOI: 10.1016/j.cell.2011.12.023

Authors: David M. Tobin, Francisco J. Roca, Sungwhan F. Oh, Ross McFarland, Thad W. Vickery, John P. Ray, Dennis C. Ko, Yuxia Zou, Nguyen D. Bang, Tran T.H. Chau, Jay C. Vary, Thomas R. Hawn, Sarah J. Dunstan, Jeremy J. Farrar, Guy E. Thwaites, Mary-Claire King, Charles N. Serhan, Lalita Ramakrishnan

Institutions: University of Washington, Duke Medical Center, Brigham and Women's Hospital, Harvard University, Pham Ngoc Thach Hospital, Hospital for Tropical Diseases, University of Oxford, Oxford University Clinical Research Unit, St Thomas' Hospital, King's College London

Language: English

Topic: Tuberculosis Research and Epidemiology

Subfield: Infectious Diseases

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

Funders: Wellcome Trust, National Institutes of Health, National Institute of Mental Health, National Institute of Allergy and Infectious Diseases

Awards: G1097973369, G1319152728, Modulating Eicosanoids to Treat Tuberculosis: Personalized, Host-directed Therapy, G7267697648

OpenAlex ID: W2128471563

FWCI: 34.44

Cites: 62

Cited by: 580

Related to: 10